Health tech and EMR software

The company shape

Health tech spans a wide range but this playbook focuses on provider-facing clinical and administrative software, the category that includes EMRs, EHRs, revenue cycle management, patient engagement, and clinical decision support. The revenue bands split cleanly into four zones. At the top sit Epic, Oracle Health (formerly Cerner), and Meditech, each running billions in revenue and locking most acute care hospitals into decade-long contracts. Below them the ambulatory mid-market runs athenahealth, eClinicalWorks, NextGen, Greenway, and Practice Fusion, each in the $200M to $1.5B ARR range and competing for the outpatient book. Specialty EHRs occupy the next zone: DrChrono for small clinics, WebPT for physical therapy, Kareo for concierge medicine, ModMed for dermatology and ophthalmology, and dozens of vertical entrants in behavioral health, dental, hospice, home health, and post-acute. Startups round out the field at $1M to $20M ARR, typically founded by clinicians who left practice to build the workflow they wanted or by technical founders paired with a physician co-founder for credibility.

Structure follows revenue. The top three operate as public companies (Oracle owns Cerner) or as employee-owned mature businesses (Epic) with global operations, legacy on-premise deployments, and multi-year rollouts measured in nine and ten figures. Mid-market players run hybrid models with cloud-hosted and on-premise instances, often reflecting the market split between multi-hospital systems and independent practices. Specialty and startup companies run cloud-first stacks with modern engineering teams of thirty to two hundred, and their commercial motion looks closer to B2B SaaS than to health system procurement. Private equity has consolidated the specialty and mid-market band aggressively over the past decade, and roll-up strategies now dominate the M&A pipeline. Founders who plan to exit inside five years plan to sell to a strategic within the same specialty or to a PE-backed platform in the category.

The economic model splits between per-provider-per-month subscription, per-encounter billing, and revenue cycle percentage takes on collected receivables. The last of these produces the largest ARR contribution for companies that bundle EMR with billing services, and it changes the marketing story fundamentally. A provider evaluating an EMR that also runs their billing is evaluating a partner that touches every dollar of cash flow. Companies that sell integrated EMR plus RCM run enterprise-grade sales cycles, six to eighteen months from first demo to signed contract. Companies that sell software only run faster cycles and higher volume, closer to standard SaaS motion.

The buyer

The buyer set changes with company size. In a solo primary care practice the physician-owner buys, often after two years of frustration with the incumbent system. In a group practice of five to twenty physicians the managing partner and the office manager buy jointly, with the office manager driving the shortlist. In a hospital or health system the buyer is a committee: the Chief Medical Information Officer, the Chief Information Officer, the Chief Financial Officer, and typically a value analysis committee that reviews any purchase above a defined threshold. In larger systems the Chief Nursing Informatics Officer and specialty department chairs weigh in on clinical workflow decisions.

Clinical and consulting influence

Influence matters as much as decision authority. End-user clinicians veto systems they find clinically unusable even when finance and IT approve. Billing teams flag systems that break their coding workflow. Front-desk staff flag systems that break patient check-in flow. Compliance and privacy officers gate any vendor that cannot demonstrate HIPAA readiness, HITRUST certification, or clean SOC 2 Type II reports. IT security teams gate any vendor without SSO, MFA, and audit logging that meets internal standards. In health systems the CMIO frequently controls the pilot: they select two or three vendors for a departmental pilot, and the pilot outcomes drive the enterprise decision six to twelve months later.

Consulting influence is real and paid for by both sides. KLAS Research publishes vendor performance reports every year, and hospital procurement teams read KLAS scores before they read a marketing site. Chartis Group, Advisory Board (now part of Optum), and Sg2 consult on system-wide EMR strategy and often participate in vendor selection. Boutique consultants like Nordic and Impact Advisors run implementation for Epic and Oracle Health customers and frequently recommend third-party point solutions during those engagements. Marketing that ignores the consultant tier misses the group that shapes the shortlist for the largest deals.

Segment differences

Segment matters. Independent primary care and specialty practices care most about workflow efficiency, patient portal usability, and integrated billing. Federally qualified health centers care about UDS reporting, sliding fee scales, and integrated behavioral health. Community hospitals care about interoperability with the regional health information exchange and about maintaining Meaningful Use attestation. Academic medical centers care about research workflow, biobank integration, and cohort discovery. Integrated delivery networks care about consolidating fifty acquired practices onto a single instance without breaking clinical workflow in any of them. The same product almost never fits every segment; positioning has to name the segment.

Discovery landscape

KLAS Research is the single most important discovery surface in provider-facing health tech. Hospital and health system buyers reference KLAS scores in every meaningful evaluation, and a strong KLAS rating on a specific product category (Ambulatory EMR, Revenue Cycle Management, Patient Engagement) opens doors that no amount of paid media buys. KLAS engagement takes time: annual customer surveys, direct participation in KLAS Konnect events, and a dedicated internal owner for the KLAS relationship. Vendors who ignore KLAS in their first three years discover in year four that they cannot get into the last round of any large system RFP.

MGMA, the Medical Group Management Association, matters for ambulatory. The annual conference draws practice administrators and physician owners, and MGMA STAT benchmarks appear in every practice manager conversation. HIMSS is the enterprise counterpart, drawing IT leadership from hospitals and vendors from every category. Attending both conferences is standard; booth strategy, side events, and speaker slots on the analytics and interoperability tracks all move pipeline. Becker's Hospital Review and HISTalk cover the industry daily, and getting placed in either drives measurable brand recognition inside CMIO and CIO circles.

Peer discovery lives on Sermo and Doximity for physicians, and on the AAPC and MGMA forums for coders and administrators. Reddit matters more than most vendors admit: r/medicine, r/nursing, r/hospitalmedicine, and specialty subreddits are where clinicians warn each other about EMRs that break workflow. Anonymous complaint posts on Reddit shape opinion inside health systems, and vendors who monitor the surface and respond substantively in public correct more misperceptions than any paid campaign.

Google still drives meaningful pipeline for practice-manager and administrator queries: "best EMR for cardiology practice," "athenahealth alternatives," "how much does Epic cost for a small hospital." Long-form comparison content ranks well and converts to demo requests at the highest rate of any surface for ambulatory. Enterprise queries convert less directly, but the enterprise buyer still Googles the vendor after a KLAS reference to check credibility signals. AI answer engines are early but growing: Perplexity and Claude increasingly show up in physician research on specific clinical software questions, and citation share is worth structuring for now.

G2 and Capterra move volume for practice-manager searches but carry less weight in enterprise selection. Software Advice runs high-intent lead generation to their own advantage, and vendors who plug into their lead flow pay high per-lead fees. Analyst relations matter more here than in most SaaS categories: Chilmark Research, KLAS as noted, and Gartner's Healthcare Provider Market Insights all inform enterprise buyers, and vendors that ignore analyst relations lose the enterprise book.

What breaks most often

The first failure is marketing that leads with implementation timelines instead of clinical workflow. A cardiology practice evaluating an EMR wants to know how the note-taking flow feels during a busy Monday morning clinic. A hospital CMIO wants to know how the system handles the discharge summary workflow for a complex post-surgical patient. Vendors who lead with "twelve week implementation" or "cloud-native architecture" are answering a question the clinician did not ask. Every marketing surface has to open with a clinical workflow narrative and only then transition to implementation and technical detail.

The second failure is skipping KLAS engagement in the first three years. Startup founders often assume KLAS is for the incumbents and defer participation until they have a hundred customers. By that point KLAS scores from ten of those customers are already circulating anonymously in health system procurement meetings, and the vendor has no ability to shape the narrative. Engagement starts in year one, with a formal customer reference program built for KLAS survey response.

The third failure is HIPAA fear paralysis in marketing. Vendors avoid publishing customer stories because their legal team will not approve any language that references a specific patient outcome. The result is generic marketing full of "one large health system reduced documentation time" language that no clinician trusts. The fix is investing in the legal work to publish real named-client case studies with de-identified patient scenarios reviewed and approved by client counsel. It takes six to nine months per story the first time and shrinks fast once the template exists.

The fourth failure is missing the revenue cycle story. Practices and health systems evaluate EMRs increasingly as revenue engines, not as clinical documentation tools. A vendor that cannot articulate how their EMR improves days in AR, denial rate, and collection velocity sits at a structural disadvantage against integrated EMR-RCM vendors. Marketing has to publish real revenue cycle case studies, ideally with named CFO or revenue cycle director quotes.

The fifth failure is treating specialty verticals as a general market. Cardiology, orthopedics, dermatology, behavioral health, and OB-GYN each have workflow requirements that a general EMR meets at a discount. Vendors who market a specialty vertical with generic ambulatory content lose to specialty-native competitors. Positioning by specialty, staff, content, and case studies is the price of entry once the vendor targets any specific vertical.

The sixth failure is a silent interoperability roadmap. FHIR, HL7 v2, TEFCA, and Carequality expectations grow every year, and the ONC's information blocking rules put teeth behind the requirement. Vendors who bury their FHIR API documentation three clicks deep and never publish a roadmap for TEFCA participation signal that they will be a problem partner for the health system's information exchange strategy. The fix is a public interoperability page with current certifications, roadmap dates, and named integration partners.

The seventh failure is no physician social presence. Founders and clinical leadership who never post on LinkedIn or Doximity give up the most credible marketing surface in the category. A physician-founder writing substantively about clinical workflow, EMR usability, and quality measure design produces trust that no marketing team can manufacture. The presence has to be genuinely clinical, not repackaged corporate messaging.

The Ranking Surfaces Playbook applied

Tier one: revenue this quarter

Tier 1 for this category runs SEO, E-E-A-T, AEO, and community (Sermo, Doximity, KLAS). SEO carries the ambulatory book because practice managers still Google. E-E-A-T is disproportionately weighted because buyers evaluate the clinical credibility of every content source; every long-form piece needs a clinician author with a real medical degree and specialty affiliation exposed via sameAs to their state medical board and their published research. AEO citations are growing in physician research and in health system CMIO research, and the discipline required to earn them (long-form clinical content, FAQPage schema, direct answer TL;DRs, credentialed authorship) doubles as good SEO.

Tier two: compounds over 6 to 12 months

Tier 2 runs GEO, KGO, VxSO, and analyst relations. GEO citations in Perplexity and Claude produce the same lift AEO does for the queries where Google's AI Overviews are not yet present, and the same content discipline produces both. KGO through Wikidata and Knowledge Panel appearance carries weight in enterprise evaluation because buyers verify the vendor exists as a real entity before scheduling a demo. VxSO covers product screenshots indexed for image search and clinical workflow diagrams that appear in Perplexity inline previews. Analyst relations belongs in tier 2 for ambulatory startups and tier 1 for anything selling into hospitals.

Tier three and four

Tier 3 runs CWV as table stakes, VSO as an AEO free-rider, LSO for headquarters listing, and ASO for companion mobile apps. CWV matters here more than in most B2B categories because clinical users on hospital tablets suffer from any performance regression, and the site performance signals the product performance. VSO produces occasional voice search appearance but almost no direct volume. LSO helps branded search only. ASO applies only if the vendor ships a patient-facing or clinician-facing mobile app.

Tier 4 runs GLOBO, AAO, and Web3 as low priority for most US health tech. GLOBO applies for vendors targeting Canada, UK, or Australia specifically, and hreflang for those markets is worth setting up in year two. AAO applies for agentic scheduling and administrative workflows and is a 2027 bet. Web3 has no meaningful application in provider-facing health tech and can be skipped.

The compounding logic matches the capstone case: buyers touch the brand across five to eight surfaces during a health system EMR selection, and vendors present on eight of them beat vendors dominant on three. The specific ordering above reflects the fastest path to pipeline for a health tech vendor with limited resources.

First 30 / 60 / 90 days

Days one through thirty focus on foundation. Audit the current KLAS score if the vendor is in the KLAS database, and open a KLAS relationship if not. Clean up brand entity signals: Wikidata entry, Organization schema, sameAs across Crunchbase, LinkedIn Company, G2, Capterra, KLAS, and any specialty association directory. Review every clinical claim on the site for FDA and FTC compliance and remove language that lacks a citation. Publish or refresh the interoperability page with current FHIR, HL7, and TEFCA certifications and a public roadmap. Instrument the site with Core Web Vitals monitoring and fix any red metrics on template pages. Set up the physician-founder LinkedIn cadence at two posts per week on clinical workflow topics, with real ghostwriter support that respects the founder's voice.

Days thirty through sixty focus on content and trust. Publish six long-form clinician-authored pieces on the specialty workflows the product supports, each 2,500 to 3,500 words with direct-answer TL;DR, FAQPage schema, and named clinician authorship. Publish two revenue cycle case studies with real customer references, run through client legal counsel for approval. Launch a Sermo and Doximity presence for the physician-founder with substantive posts, not repackaged marketing. Open outreach to Chilmark Research and Chartis Group for briefings and get on the Becker's Hospital Review pitch calendar. Ship the first quarterly KLAS customer survey campaign. Add HITRUST and SOC 2 badges to the site if certified, and open certification pathways if not.

Days sixty through ninety focus on discovery share and enterprise readiness. Ship AI answer engine structuring across every long-form piece: TL;DR at 70 words, FAQ schema on the top three questions, HowTo schema on procedural content. Launch the analyst relations program with formal briefings for KLAS, Chilmark, and Gartner. Build the health system reference program with three named-client references per segment. Ship a public FHIR sandbox for developer partners and put the API documentation one click from the homepage. Instrument attribution to track which surface each demo request came from, and calibrate ninety-day investment weights against surface conversion rates. By day ninety the vendor should be visible on Google, in AI Overview citations for at least two category queries, in KLAS with an active reference program, in one analyst briefing calendar, and on the physician social surfaces that shape peer opinion. The pipeline lift shows up in month four or five, and the KLAS engagement pays off in month twelve when the vendor makes the shortlist for the enterprise deals that used to close them out.